At this time, I would like to welcome everyone to the Exact Sciences third-quarter 2024 earnings conference call. [Operator ...

Cologuard was about three times more likely to give a false positive result — meaning no cancer was found on the follow-up colonoscopy. Lives saved. The bottom line for any cancer screening test ...

The Cologuard test result should be interpreted with caution. A positive test result does not confirm the presence of cancer. Patients with a positive test result should be referred for colonoscopy.

The Cologuard test performance in repeat testing has not been evaluated. The Cologuard test result should be interpreted with caution. A positive test result does not confirm the presence of cancer.

Cologuard is an at-home colon cancer screening kit that detects changes in genetic material indicating potential cancer or polyps. Medicare covers one kit per year under Original Medicare (Parts A and ...

Exact Sciences issued a news release earlier this afternoon detailing our third quarter financial results ... positive rates. Per the modeling assumptions that inform USPSTF guidelines, only ...

Exact Sciences shares plunged Wednesday after the company reported widening losses. The maker of the Cologuard colon cancer screening test lowered its full-year outlook. CEO Kevin Conroy said the ...

Despite the weaker than expected results, Exact Sciences announced several pipeline advancements, including FDA approval for its next-generation Cologuard Plus test and promising data from its ...

Study participants (N=20,176) provided stool samples that were then tested with both Cologuard Plus and FIT; colonoscopy results were used as the reference standard. In this study population ...

Speaking in a post-match press conference, Olowookere said the team was focused on getting more positive results. “We kicked off our campaign in the FIFA U-17 Women’s World Cup in the ...